突变型PfCRT可介导非洲恶性疟原虫对哌喹耐药且适合度降低、对其他抗疟药敏感性增加
研究将东南亚已知介导高水平哌喹耐药的两个PfCRT突变编辑入加蓬GB4恶性疟原虫,用抗疟药浓度-反应与适合度试验评估。PfCRT F145I在GB4中介导中度哌喹耐药但适合度代价大,G353V未见耐药;两个编辑克隆对阿莫地喹、氯喹和奎宁均显著更敏感。作者认为单一PfCRT突变可介导GB4哌喹耐药,但生长缺陷可能限制其在无进一步遗传适应时扩散。
要点
- PfCRT F145I在GB4虫株中介导中度哌喹耐药,但伴随显著适合度代价。
- PfCRT G353V突变在GB4虫株中未观察到哌喹耐药。
- 两个基因编辑克隆对阿莫地喹、氯喹和奎宁均显著更敏感。
核心结论
- 单一PfCRT突变可在GB4虫株中介导哌喹耐药,但生长缺陷可能使其在无进一步遗传适应时难以扩散。
- 作者认为研究结果支持在区域内使用对PfCRT施加相反选择压力的药物组合。
研究设计与样本
- 研究将两个已知在东南亚介导高水平哌喹耐药的PfCRT突变编辑入来自加蓬的GB4恶性疟原虫。
- 对基因编辑克隆进行抗疟药浓度-反应试验与适合度试验。
主要发现
- PfCRT F145I突变在GB4虫株中介导中度哌喹耐药,但伴随显著适合度代价。
- PfCRT G353V突变体未观察到耐药。
- 两个编辑克隆对阿莫地喹、氯喹和奎宁均显著更敏感。
临床怎么用
- 作者认为研究结果支持区域内使用对PfCRT施加相反选择压力的药物组合。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Additional therapeutic strategies could benefit efforts to reverse the recent increase in malaria cases in sub-Saharan Africa, which mostly affects young children. A primary candidate is dihydroartemisinin + piperaquine (DHA + PPQ), which is effective for uncomplicated malaria treatment, seasonal malaria chemoprevention, and intermittent preventive treatment. In Southeast Asia, Plasmodium falciparum parasites acquired PPQ resistance, mediated primarily by mutations in the P falciparum chloroquine resistance transporter PfCRT. The recent emergence in Africa of DHA-resistant parasites creates an imperative to assess whether PPQ resistance could emerge in African parasites with distinct PfCRT isoforms. METHODS: We edited 2 PfCRT mutations known to mediate high-grade PPQ resistance in Southeast Asia into GB4 parasites from Gabon. Gene-edited clones were profiled in antimalarial concentration-response and fitness assays. RESULTS: The PfCRT F145I mutation mediated moderate PPQ resistance in GB4 parasites but with a substantial fitness cost. No resistance was observed with the PfCRT G353V mutant. Both edited clones became significantly more susceptible to amodiaquine, chloroquine, and quinine. CONCLUSIONS: A single PfCRT mutation can mediate PPQ resistance in GB4 parasites, but with a growth defect that may preclude its spread without further genetic adaptations. Our findings support regional use of drug combinations that exert opposing selective pressures on PfCRT.
引用
- Wicht KJ, Small-Saunders JL, Hagenah LM, et al. Mutant PfCRT Can Mediate Piperaquine Resistance in African Plasmodium falciparum With Reduced Fitness and Increased Susceptibility to Other Antimalarials. J Infect Dis. 2022. PMID: 36082431. doi:10.1093/infdis/jiac365
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。